Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 43 of the 45 references it cites were found in a registry or an index.

Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Open access

Abstract

Anemia is the most prevalent extraintestinal complication of inflammatory bowel disease (IBD). Our aim was to evaluate the comparative efficacy and harm of intravenous (IV) versus oral iron supplementation for correcting anemia in adult IBD patients.We conducted a systematic review and meta-analysis to integrate evidence from randomized controlled trials having enrolled adults with IBD, and comparing IV versus oral iron (head-to-head) for correcting iron-deficiency anemia. Medline, Embase, Scopus, and the Web of Science database were searched through July 2015. The Cochrane Central Register of Controlled Trials, the WHO International Clinical Trials Registry Platform, the ClinicalTrials.gov, and international conference proceedings were also investigated. Two reviewers independently abstracted study data and outcomes, and rated each trial's risk-of-bias. Pooled odds ratio (OR) estimates with their 95% CIs were calculated using fixed- and random-effects models.Five eligible studies, including 694 IBD patients, were identified. In meta-analysis, IV iron demonstrated a higher efficacy in achieving a hemoglobin rise of ≥2.0 g/dL as compared to oral iron (OR: 1.57, 95% CI: 1.13, 2.18). Treatment discontinuation rates, due to adverse events or intolerance, were lower in the IV iron groups (OR: 0.27, 95% CI: 0.13, 0.59). Similarly, the occurrence of gastrointestinal adverse events was consistently lower in the IV iron groups. On the contrary, serious adverse events (SAEs) were more frequently reported among patients receiving IV iron preparations (OR: 4.57, 95% CI: 1.11, 18.8); however, the majority of the reported SAEs were judged as unrelated or unlikely to be related to the study medication. We found no evidence of publication bias, or between-study heterogeneity, across all analyses. Risk of bias was high across primary studies, because patients and personnel were not blinded to the intervention.IV iron appears to be more effective and better tolerated than oral iron for the treatment of IBD-associated anemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000002308

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Summary of the evidence search and selection process. IBD = inflammatory bowel disease, RCTs = randomized controlled trials.
FIGURE 1 Summary of the evidence search and selection process. IBD = inflammatory bowel disease, RCTs = randomized controlled trials.CC BY-ND · PubMed Central
FIGURE 2 Risk-of-bias assessment for the randomized trials included in the meta-analysis. Symbols: green (+), low risk of bias; yellow (?), unclear risk of bias; red (−), high risk of bias.
FIGURE 2 Risk-of-bias assessment for the randomized trials included in the meta-analysis. Symbols: green (+), low risk of bias; yellow (?), unclear risk of bias; red (−), high risk of bias.CC BY-ND · PubMed Central
FIGURE 3 Forest plot for hemoglobin response (ie, increase of ≥2.0 g/dL): results from individual studies and meta-analysis. CI = confidence interval, IV = intravenous, OR = odds ratio.
FIGURE 3 Forest plot for hemoglobin response (ie, increase of ≥2.0 g/dL): results from individual studies and meta-analysis. CI = confidence interval, IV = intravenous, OR = odds ratio.CC BY-ND · PubMed Central
FIGURE 4 “Leave-one-out” sensitivity analysis for hemoglobin response (ie, increase of ≥2.0 g/dL): pooled estimates are from random-effects models, with 1 study omitted at a time. CI = confidence interval, OR = odds ratio.
FIGURE 4 “Leave-one-out” sensitivity analysis for hemoglobin response (ie, increase of ≥2.0 g/dL): pooled estimates are from random-effects models, with 1 study omitted at a time. CI = confidence interval, OR = odds ratio.CC BY-ND · PubMed Central
FIGURE 5 Forest plot for treatment discontinuation, due to adverse events or intolerance: results from individual studies and meta-analysis. CI = confidence interval, IV = intravenous, OR = odds ratio.
FIGURE 5 Forest plot for treatment discontinuation, due to adverse events or intolerance: results from individual studies and meta-analysis. CI = confidence interval, IV = intravenous, OR = odds ratio.CC BY-ND · PubMed Central
FIGURE 6 Forest plot for serious adverse events: results from individual studies and meta-analysis. CI = confidence interval, IV = intravenous, OR = odds ratio.
FIGURE 6 Forest plot for serious adverse events: results from individual studies and meta-analysis. CI = confidence interval, IV = intravenous, OR = odds ratio.CC BY-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. Schwarzer, 2007, meta: an R package for meta-analysis, R News, 7, 40

Cited by

See all 113

Metadata

Authors
Bonovas, S., Fiorino, G., Allocca, M., Lytras, T., Tsantes, A., Peyrin-Biroulet, L., & Danese, S.
Affiliations
Humanitas University (IT)
Corresponding author
Bonovas, Stefanos
Venue
Medicine
Published
2016-01
Volume
95
Issue
2
Pages
e2308
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2312546894
Cited by
113
References
45
Citations by year
2026: 4 · 2025: 12 · 2024: 12 · 2023: 7 · 2022: 14 · 2021: 21 · 2020: 14 · 2019: 5 · 2018: 9 · 2017: 10 · 2016: 3
FWCI
8.56
Type
journal article
Language
en
Open access
Licence
cc-by-nd
Locations
  • Medicine (publishedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by-nd)
  • PubMed (publishedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion, cc-by-nd)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by-nd)
  • HAL (submittedVersion, cc-by-nc-sa)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by-nd)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
inflammatory bowel disease, iron deficiency anemia, intravenous iron, oral iron supplementation, hemoglobin response, treatment discontinuation, gastrointestinal adverse effects, serious adverse events, tolerability
MeSH terms
Administration, Oral, Gastrointestinal Diseases, Humans, Iron, Inflammatory Bowel Diseases, Treatment Outcome, Anemia, Iron-Deficiency, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. https://app.cochat.ai/papers/10.1097/md.0000000000002308
The paper
Bonovas, S., Fiorino, G., Allocca, M., Lytras, T., Tsantes, A., Peyrin-Biroulet, L., & Danese, S. (2016). Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine. https://doi.org/10.1097/md.0000000000002308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.